New drug trial for aggressive blood cancers ends early
NCT ID NCT05961839
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This early-stage study tested a new drug called SGR-2921 in adults with relapsed or refractory acute myeloid leukemia or high-risk myelodysplastic syndrome. The main goal was to find a safe dose and check for side effects. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Oncology Associates of Oregon, P.C.
Eugene, Oregon, 97401, United States
-
Oregon Health & Science University - Knight Cancer Institute - Center of Hematologic Malignancies
Portland, Oregon, 97239, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
St. David's South Austin Medical Center
Austin, Texas, 78745, United States
-
The Ohio State University Wexner Medical Center - James Cancer Hospital
Columbus, Ohio, 43210, United States
-
The University of Kansas Clinical Research Center
Fairway, Kansas, 66205, United States
-
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization
Philadelphia, Pennsylvania, 19107, United States
-
TriStar Bone Marrow Transplant, LLC
Nashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.